ILROG
Home Research Blog
LOGIN
History & Objectives Team
2023 ILROG Conference Upcoming Meetings Past Meetings
Guidelines Publications Resources for Trainees Resident Elective IJROBP 2015 Special Edition Youtube
Membership Twitter Contact Ask an Expert!
Home About History & Objectives Team Meetings 2023 ILROG Conference Upcoming Meetings Past Meetings Research Resources Guidelines Publications Resources for Trainees Resident Elective IJROBP 2015 Special Edition Youtube Blog Get Connected Membership Twitter Contact Ask an Expert!
ILROG
LOGIN

ILROG Guidelines

 

Technical Considerations

2020 - Involved site radiation therapy in adult lymphomas: An overview of ILROG guidelines

2020 - Making every single gray count: Involved site radiation therapy delineation guidelines for hematological malignancies

2019 - The optimal use of imaging in radiation therapy for lymphoma: guidelines from ILROG

RT for Lymphomas during COVID-19

2020 - ILROG emergency guidelines for RT of hematological malignancies during the COVID-19 pandemic

Hodgkin Lymphoma

2014 - Modern RT for Hodgkin Lymphoma

2018 - The Role of RT in Patients with Relapsed or Refractory Hodgkin Lymphoma

Non-Hodgkin Lymphoma

2014 - Modern RT for Nodal NHL

2015 - Modern RT for Extranodal Lymphomas:

2018 - Role of RT in Patients With Relapsed/Refractory DLBCL

Chloroma and Leukemia

2018 - Total Body Irradiation

2018 - Radiation in CNS Leukemia

Lymphoblastic Lymphoma

2018 - Lymphoblastic Lymphoma

Primary Cutaneous Lymphoma

2015 - Modern RT for Primary Cutaneous Lymphomas

Solitary Plasmacytoma and Multiple Myeloma

2018 - RT for Solitary Plasmacytoma and Multiple Myeloma

Proton Therapy

2018 - Proton Therapy for Adults with Mediastinal Lymphoma

International Lymphoma Radiology Oncology Group
1275 York Avenue,
New York, NY, 10065,
United States
+1 (646) 608-2639 fregoneseb@ILROG.com
Hours
logo-small.png
AboutMeetingsResearchResourcesBlogGet Connected

© 2024 ILROG. All Rights Reserved.
Design by Mediaspace